These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3724142)

  • 41. An antiestrogen-binding protein in human tissues.
    Kon OL
    J Biol Chem; 1983 Mar; 258(5):3173-7. PubMed ID: 6826555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines.
    Lewis JB; Lapp CA; Schafer TE; Wataha JC; Randol TM; Schuster GS
    In Vitro Cell Dev Biol Anim; 2000 May; 36(5):320-6. PubMed ID: 10937835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements.
    Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R
    Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
    Winneker RC; Clark JH
    Endocrinology; 1983 Jun; 112(6):1910-5. PubMed ID: 6682755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-resolution separation of molybdate-stabilized progestin receptors using high-performance liquid chromatography.
    van der Walt LA; Wittliff JL
    J Chromatogr; 1988 Mar; 425(2):277-91. PubMed ID: 3372642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation and immunorecognition by a monoclonal antibody of the tamoxifen-estrogen receptor complex.
    Giambiagi N; Pasqualini JR
    Biochim Biophys Acta; 1986 Oct; 883(3):559-66. PubMed ID: 3756221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells--relationship between processing and estrogenicity.
    Gyling M; Leclercq G
    J Steroid Biochem; 1988 Jan; 29(1):1-8. PubMed ID: 3347042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiestrogen binding sites in rat liver nuclei.
    Kon OL
    Biochim Biophys Acta; 1985 Dec; 843(3):245-53. PubMed ID: 4063396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of membrane estrogen binding proteins from rabbit uterus.
    Monje P; Boland R
    Mol Cell Endocrinol; 1999 Jan; 147(1-2):75-84. PubMed ID: 10195694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
    Toko T; Shibata J; Nukatsuka M; Yamada Y
    Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of [3H] monohydroxytamoxifen in ovarian carcinoma.
    Holt JA; Jordan VC; Tate AC; Lorincz MA
    Br J Obstet Gynaecol; 1983 Aug; 90(8):751-8. PubMed ID: 6882707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
    Borgna JL; Rochefort H
    Mol Cell Endocrinol; 1980 Oct; 20(1):71-85. PubMed ID: 7439523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogenicity of coumestrol in the mouse: fluorescence detection of interaction with estrogen receptors.
    Nelson K; Pavlik EJ; van Nagell JR; Hanson MB; Donaldson ES; Flanigan RC
    Biochemistry; 1984 Jun; 23(12):2565-72. PubMed ID: 6466599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The binding of estrogen and estrogen antagonists to the estrogen receptor.
    Bond JP; Sasson S; Notides AC
    Arch Biochem Biophys; 1992 Aug; 296(2):583-91. PubMed ID: 1632645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor.
    Parisot JP; Hu XF; Sutherland RL; Wakeling A; Zalcberg JR; DeLuise M
    Int J Cancer; 1995 Aug; 62(4):480-4. PubMed ID: 7635575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HPLC analysis of estrogen receptor by a multidimensional approach.
    Shahabi NA; Hyder SM; Wiehle RD; Wittliff JL
    J Steroid Biochem; 1986 Jun; 24(6):1151-7. PubMed ID: 3736041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site.
    Berthois Y; Pons M; Dussert C; Crastes de Paulet A; Martin PM
    Mol Cell Endocrinol; 1994 Mar; 99(2):259-68. PubMed ID: 8206333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.